TG01: Completed Phase I/II enrollment

Targovax completed enrollment of 32 patients with surgically resected pancreatic cancer

Read the full 110 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE